News OPTIC Confirms Teprotumumab Benefit in Thyroid Eye Disease by Medscape • 2019/04/27 • 0 Comments Phase 3 findings support practice-changing use of the IGF-1R inhibitor for treating active thyroid-associated ophthalmopathy. Medscape Medical News Full Story →